Johnson & Johnson clears a key OTTAVA hurdle, but the harder robotics test comes next
Robotic surgery is opening up. Johnson & Johnson’s OTTAVA data may test whether hospitals want a new soft tissue platform.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Why Johnson & Johnson’s new ETHICON 4000 stapler could matter for European surgical workflow economics
Read how Johnson & Johnson’s ETHICON 4000 CE Mark approval could reshape surgical stapling, hospital economics, and future robotic integration.